The gathered evidence suggests that a reduction in GREM1 does affect the fertilisation rates and EDR, particularly in suboptimal cohorts, such as decrease ovarian reserved (DOR), or in cases of poor oocyte quality in women with endometriosis or polycystic ovarian syndrome (13, 43, 44). Here, GREM1 is linked to endometriosis.